Back to Search
Start Over
Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy.
- Source :
-
Journal of vascular surgery [J Vasc Surg] 2012 Jan; Vol. 55 (1), pp. 79-89; discussion 88-9. Date of Electronic Publication: 2011 Nov 03. - Publication Year :
- 2012
-
Abstract
- Background: Diabetes is prevalent in most patients undergoing carotid revascularization and is suggested as a marker of poor outcome after carotid endarterectomy (CEA). Data on outcome of diabetic patients undergoing carotid artery stenting (CAS) are limited. The aim of this study was to investigate early and 6-year outcomes of diabetic patients undergoing carotid revascularization with CAS and CEA.<br />Methods: The database of patients undergoing carotid revascularization for primary carotid stenosis was queried from 2001 to 2009. Diabetic patients were defined as those with established diagnosis and/or receiving oral hypoglycemic or insulin therapy. Multivariate and Kaplan- Meier analyses, stratified by type of treatment, were performed on perioperative (30 days) and late outcomes.<br />Results: A total of 2196 procedures, 1116 by CEA and 1080 by CAS (29% female, mean age 71.3 years), were reviewed. Diabetes was prevalent in 630 (28.7%). Diabetic patients were younger (P < .0001) and frequently had hypertension (P = .018) or coronary disease (P = .019). Perioperative stroke/death rate was 2.7% (17/630) in diabetic patients vs 2.3% (36/1566) in nondiabetic, (P = .64); the rate was 3.4% in diabetic CEA group and 2.1% in diabetic CAS group (P = .46). At multivariate analyses, diabetes was a predictor of perioperative stroke/death in the CEA group (odds ratio [OR], 2.83; 95% confidence interval [CI], 1.05-7.61; P = .04) but not in the CAS group (P = .72). Six-year survival was 76.0% in diabetics and 80.8% in nondiabetics (P = .15). Six-year late stroke estimates were 3.2% in diabetic and 4.6% in nondiabetic patients (P = .90). The 6-year risk of restenosis was similar (4.6% % vs 4.2%) in diabetic and nondiabetic patients (P = .56). Survival, late stroke, and restenosis rates between diabetics and nondiabetics were similar in CAS and CEA groups.<br />Conclusions: Diabetic patients are not at greater risk of perioperative morbidity and mortality or late stroke after CAS, however, the perioperative risk can be higher after CEA. This may help in selecting the appropriate technique for carotid revascularization in patients best suited for the type of procedure.<br /> (Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.)
- Subjects :
- Administration, Oral
Aged
Angioplasty adverse effects
Angioplasty mortality
Carotid Stenosis mortality
Carotid Stenosis surgery
Chi-Square Distribution
Diabetes Complications mortality
Female
Humans
Hypoglycemic Agents administration & dosage
Injections
Insulin administration & dosage
Italy
Kaplan-Meier Estimate
Male
Middle Aged
Odds Ratio
Patient Selection
Prevalence
Proportional Hazards Models
Retrospective Studies
Risk Assessment
Risk Factors
Stroke mortality
Survival Rate
Time Factors
Treatment Outcome
Angioplasty instrumentation
Carotid Stenosis therapy
Diabetes Complications etiology
Diabetes Mellitus diagnosis
Diabetes Mellitus drug therapy
Diabetes Mellitus mortality
Endarterectomy, Carotid adverse effects
Endarterectomy, Carotid mortality
Stents
Stroke etiology
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6809
- Volume :
- 55
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of vascular surgery
- Publication Type :
- Academic Journal
- Accession number :
- 22056251
- Full Text :
- https://doi.org/10.1016/j.jvs.2011.07.080